Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)
Status:
Completed
Trial end date:
2018-09-18
Target enrollment:
Participant gender:
Summary
The French cooperative group GINECO proposes to implement an observational study to describe
a real situation, in daily practice tolerance and methods of administration of trabectedin
(Yondelis®)-Pegylated liposomal doxorubicin(Caelyx)®, in ovarian platinum sensitive cancer
relapse.